Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Postoperative Use of Bisphosphonates Reduces Adverse Outcome After Primary Total Joint Arthroplasty: A Nationwide Population-based Cohort Study

NCT05623540 is registered in ClinicalTrials.gov with National Defense Medical Center, Taiwan as lead sponsor.

NCT NCT05623540
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05623540 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Postoperative Use of Bisphosphonates Reduces Adverse Outcome After Primary Total Joint Arthroplasty: A Nationwide Population-based Cohort Study
Lead sponsor
National Defense Medical Center, Taiwan
Phase
Observational
Overall status
Completed
Start date
January 1, 2000
Completion date
November 2, 2022
Enrollment
27,405 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diphosphonates